Skip to content

The effects of peptide on mood states : A randomized, double-blind, placebo-controlled study

The effects of peptide on mood states : A randomized, double-blind, placebo-controlled study - The effects of peptide on mood states : A randomized, double-blind, placebo-controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000054349
Enrollment
200
Registered
2024-05-13
Start date
2024-05-14
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Intake of powder containing peptide for 12 weeks Intake of placebo powder for 12 weeks

Sponsors

Matsumoto City Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Subjects aged 18-64 years

Exclusion criteria

Exclusion criteria: 1) Subjects who have serious illness or medical history such as heart, liver, kidney, respiratory, digestive, etc. or lifestyle-related diseases (diabetes, hyperlipidemia, etc.) 2) Subjects who use foods and drugs associated with mental health. 3) Subjects who have or have history of depression or suspicion of mental disorder. 4) Subjects with chronic fatigue syndrome. 5) Subjects who have severe drug allergies or severe food allergies. 6) Subjects whose BMIs are >=30. 7) Subjects drink alcohol polydipsia (pure alcohol equivalent more than 60 g/day) 8) Subjects who participated in other clinical trials or participated in clinical trials of other drugs or foods within one month before the date of consent acquisition. 9) Subjects who are pregnant or lactating, or who are expected to be pregnant during the study. 10) Subjects who are judged inappropriate to this trial by the principal investigator.

Design outcomes

Primary

MeasureTime frame
POMS2 Japanese Adult Short version

Secondary

MeasureTime frame
Subjective fatigue (Visual Analog Scale)

Countries

Japan

Contacts

Public ContactKatsuya Furuhata

Matsumoto Health Lab None

info@m-health-lab.jp0263-39-1139

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026